Mesenchymal stem cells (MSC s) are broadly used in cell‐based regenerative medicine
because of their self‐renewal and multilineage potencies in vitro and in vivo. To ensure …

The repair of articular cartilage is challenging due to the sparse native cell population
combined with the avascular and aneural nature of the tissue. In recent years, cartilage …

The translational potential of mesenchymal stem/stromal cells (MSCs) is limited by their
rarity in somatic organs, heterogeneity, and need for harvest by invasive procedures …

Background aims Clinical trials have documented beneficial effects of mesenchymal stromal
cells from bone marrow and adipose tissue (ASCs) as treatment in patients with ischemic …

Efficient xenofree expansion methods to replace fetal bovine serum (FBS)-based culture
methods are strongly encouraged by the regulators and are needed to facilitate the adoption …

We have previously identified and purified multipotent mesenchymal stromal cell (MSC)-like
cells in the highly regenerative endometrial lining of the human uterus (eMSC) as CD140b+ …

Synthetic microRNAs regulate gene expression when transfected into cells, and may be
used in strategies for molecular therapy both in vitro and in vivo. Liposomal transfection …

Mesenchymal stem cells (MSCs) are an ideal cell source for tissue engineering and
regenerative medicine as they possess self-renewal properties and multilineage …

Osteogenesis of mesenchymal stem cells (MSCs) is highly dependent on oxygen supply.
We have shown that perfluorotributylamine (PFTBA), a synthetic oxygen carrier, enhances …

The present communication investigates an application of alginate encapsulation
technology to the differentiation of the embryonic cancer stem NTera2 cells (NT2) into …